0001127602-20-030093.txt : 20201130
0001127602-20-030093.hdr.sgml : 20201130
20201130104730
ACCESSION NUMBER: 0001127602-20-030093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201125
FILED AS OF DATE: 20201130
DATE AS OF CHANGE: 20201130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bihl Anthony P III
CENTRAL INDEX KEY: 0001432665
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 201356788
MAIL ADDRESS:
STREET 1: 807 SMITH RIDGE ROAD
CITY: NEW CANAAN
STATE: CT
ZIP: 06840
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-11-25
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001432665
Bihl Anthony P III
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
1
Common Stock
2020-11-25
4
P
0
5000
17.6531
A
10851
D
Prices range from $17.5790 per share to $17.6700 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
/s/ Bryan T. Baldasare, as Attorney-in-Fact for Anthony P. Bihl III
2020-11-30